BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29678284)

  • 1. Aberrant G-protein coupled hormone receptor in adrenal diseases.
    St-Jean M; Ghorayeb NE; Bourdeau I; Lacroix A
    Best Pract Res Clin Endocrinol Metab; 2018 Apr; 32(2):165-187. PubMed ID: 29678284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple aberrant hormone receptors in Cushing's syndrome.
    El Ghorayeb N; Bourdeau I; Lacroix A
    Eur J Endocrinol; 2015 Oct; 173(4):M45-60. PubMed ID: 25971648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction.
    Lacroix A; Bourdeau I; Lampron A; Mazzuco TL; Tremblay J; Hamet P
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):1-15. PubMed ID: 19719763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant hormone receptors in primary aldosteronism.
    Mazzuco TL; Grunenwald S; Lampron A; Bourdeau I; Lacroix A
    Horm Metab Res; 2010 Jun; 42(6):416-23. PubMed ID: 20503136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome.
    Assie G; Louiset E; Sturm N; René-Corail F; Groussin L; Bertherat J; Thomas M; Lefebvre H; Feige JJ; Clauser E; Chabre O; Cherradi N
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E253-62. PubMed ID: 20660048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP-dependent signaling aberrations in macronodular adrenal disease.
    Bourdeau I; Stratakis CA
    Ann N Y Acad Sci; 2002 Jun; 968():240-55. PubMed ID: 12119280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of primary bilateral macronodular adrenal hyperplasia.
    Vassiliadi DA; Tsagarakis S
    Endocr Relat Cancer; 2019 Oct; 26(10):R567-R581. PubMed ID: 32053747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of Adrenocoricotrophic hormone -independent bilateral adrenocortical macronodular hyperplasia concomitant with primary aldosteronism.
    Tokumoto M; Onoda N; Tauchi Y; Kashiwagi S; Noda S; Toi N; Kurajoh M; Ohsawa M; Yamazaki Y; Sasano H; Hirakawa K; Ohira M
    BMC Surg; 2017 Sep; 17(1):97. PubMed ID: 28877721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of glucagon receptors in adrenal glands of a patient with Cushing's syndrome and ACTH-independent macronodular adrenal hyperplasia.
    de Miguel V; Redal MA; Viale ML; Kahan M; Glerean M; Beskow A; Fainstein Day P
    Medicina (B Aires); 2010; 70(3):254-6. PubMed ID: 20529775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of Cushing's syndrome due to primary bilateral macronodular adrenal hyperplasia secondary to aberrant adrenal expression of hormone receptors.
    Juliá-Sanchis MLL; Navarro-Téllez MDP; Falcones-Gracia KV; Ricart-Álvarez E; González-Bueno MV; Molina-Gasset R
    Clin Biochem; 2018 Sep; 59():86-89. PubMed ID: 29936051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing's syndrome.
    Mazzuco TL; Thomas M; Martinie M; Cherradi N; Sturm N; Feige JJ; Chabre O
    Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1452-62. PubMed ID: 18209887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome.
    de Groot JW; Links TP; Themmen AP; Looijenga LH; de Krijger RR; van Koetsveld PM; Hofland J; van den Berg G; Hofland LJ; Feelders RA
    Eur J Endocrinol; 2010 Aug; 163(2):293-9. PubMed ID: 20460422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cushing's syndrome secondary to ACTH-independent macronodular adrenal hyperplasia.
    Costa MH; Lacroix A
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1226-37. PubMed ID: 18209860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.
    Miyamura N; Taguchi T; Murata Y; Taketa K; Iwashita S; Matsumoto K; Nishikawa T; Toyonaga T; Sakakida M; Araki E
    Endocrine; 2002 Dec; 19(3):319-26. PubMed ID: 12624433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological correlates of adrenal Cushing's syndrome.
    Duan K; Gomez Hernandez K; Mete O
    J Clin Pathol; 2015 Mar; 68(3):175-86. PubMed ID: 25425660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of hormone receptors in adrenal Cushing's syndrome.
    Christopoulos S; Bourdeau I; Lacroix A
    Pituitary; 2004; 7(4):225-35. PubMed ID: 16010457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism.
    Bertherat J; Contesse V; Louiset E; Barrande G; Duparc C; Groussin L; Emy P; Bertagna X; Kuhn JM; Vaudry H; Lefebvre H
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1302-10. PubMed ID: 15585558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia.
    Bertherat J; Bourdeau I; Bouys L; Chasseloup F; Kamenický P; Lacroix A
    Endocr Rev; 2023 Jul; 44(4):567-628. PubMed ID: 36548967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New insights in adrenal Cushing syndrome].
    Haissaguerre M; Tabarin A
    Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S37-45. PubMed ID: 25617921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates.
    Louiset E; Contesse V; Groussin L; Cartier D; Duparc C; Perraudin V; Bertherat J; Lefebvre H
    J Endocrinol; 2008 Jan; 196(1):1-9. PubMed ID: 18180312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.